相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Sulfatide-Reactive Natural Killer T Cells Abrogate Ischemia-Reperfusion Injury
Seung Hee Yang et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
In vivo activity of epoxide hydrolase according to sequence variation affects the progression of human IgA nephropathy
Jung Pyo Lee et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2011)
The interaction between ischemia-reperfusion and immune responses in the kidney
Hye Ryoun Jang et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2009)
Early exposure to germs modifies kidney damage and inflammation after experimental ischemia-reperfusion injury
Hye Ryoun Jang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2009)
Soluble epoxide hydrolase gene deletion attenuates renal injury and inflammation with DOCA-salt hypertension
Marlina Manhiani et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2009)
Soluble epoxide hydrolase inhibition and gene deletion are protective against myocardial ischemia-reperfusion injury in vivo
Atsuko Motoki et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
An essential role for SRC-activated STAT-3 in 14,15-EET-induced VEGF expression and angiogenesis
Sergey Y. Cheranov et al.
BLOOD (2008)
Genetic variations in soluble epoxide hydrolase and graft function in kidney transplantation
S. H. Lee et al.
TRANSPLANTATION PROCEEDINGS (2008)
Renal ischemia reperfusion inhibits VEGF expression and induces ADAMTS-1, a novel VEGF inhibitor
David P. Basile et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2008)
Hypoxia and the HIF system in kidney disease
Masaomi Nangaku et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2007)
Soluble epoxide hydrolase: a novel therapeutic target in stroke
Wenri Zhang et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2007)
Polymorphisms in the human soluble epoxide hydrolase gene EPHX2 linked to neuronal survival after ischemic injury
Ines P. Koerner et al.
JOURNAL OF NEUROSCIENCE (2007)
Design of bioavailable derivatives of 12-(3-adamantan-1-yl-ureido)dodecanoic acid, a potent inhibitor of the soluble epoxide hydrolase
In-Hae Kim et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2007)
Role of epoxyeicosatrienoic acids in protecting the myocardium following ischemia/reperfusion injury
John M. Seubert et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2007)
Prevention and reversal of cardiac hypertrophy by soluble epoxide hydrolase inhibitors
Danyan Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Role of soluble epoxide hydrolase in postischemic recovery of heart contractile function
John M. Seubert et al.
CIRCULATION RESEARCH (2006)
Hypoxia-inducible factors in the kidney
Volker H. Haase
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2006)
Genetic variation in soluble epoxide hydrolase (EPHX2) and risk of coronary heart disease:: The Atherosclerosis Risk in Communities (ARIC) study
CR Lee et al.
HUMAN MOLECULAR GENETICS (2006)
Patients with ischaemic, mixed and nephrotoxic acute tubular necrosis in the intensive care unit - a homogeneous population?
Wilson J. Q. Santos et al.
CRITICAL CARE (2006)
An epoxide hydrolase inhibitor, 12-(3-adamantan-1-yl-ureido)dodecanoic acid (AUDA), reduces ischemic cerebral infarct size in stroke-prone spontaneously hypertensive rats
AM Dorrance et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2005)
An orally active epoxide hydrolase inhibitor lowers blood pressure and provides renal protection in salt-sensitive hypertension
JD Imig et al.
HYPERTENSION (2005)
The soluble epoxide hydrolase gene harbors sequence variation associated with susceptibility to and protection from incident ischemic stroke
M Fornage et al.
HUMAN MOLECULAR GENETICS (2005)
Hypoxic preconditioning and tolerance via hypoxia inducible factor (HIF) 1α-linked induction of P450 2C11 epoxygenase in astrocytes
M Liu et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2005)
Soluble epoxide hydrolase is a therapeutic target for acute inflammation
KR Schmelzer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Soluble epoxide hydrolase is a main effector of angiotensin II-induced hypertension
O Jung et al.
HYPERTENSION (2005)
Epoxide hydrolase and epoxygenase metabolites as therapeutic targets for renal diseases
JD Imig
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2005)
Polymorphism of the soluble epoxide hydrolase is associated with coronary artery calcification in African-American subjects - The Coronary Artery Risk Development in Young Adults (CARDIA) study
M Fornage et al.
CIRCULATION (2004)
Effect of soluble epoxide hydrolase inhibition on epoxyeicosatrienoic acid metabolism in human blood vessels
X Fang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2004)
The simultaneous quantification of cytochrome P450 dependent linoleate and arachidonate metabolites in urine by HPLC-MS/MS
JW Newman et al.
JOURNAL OF LIPID RESEARCH (2002)
Expression of hypoxia-inducible factor-1α and -2α in hypoxic and ischemic rat kidneys
C Rosenberger et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2002)
Heparin-binding EGF-like growth factor mediates the biological effects of P450 arachidonate epoxygenase metabolites in epithelial cells
JK Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Interleukin-10 inhibits ischemic and cisplatin-induced acute renal injury
JP Deng et al.
KIDNEY INTERNATIONAL (2001)
Renal ischemic injury results in permanent damage to peritubular capillaries and influences long-term function
DP Basile et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2001)
Epoxygenase pathways of arachidonic acid metabolism
DC Zeldin
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Targeted disruption of soluble epoxide hydrolase reveals a role in blood pressure regulation
CJ Sinal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
